Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001387131-23-007431
Filing Date
2023-06-08
Accepted
2023-06-08 17:14:37
Documents
20

Document Format Files

Seq Description Document Type Size
1 ADDITIONAL DEFINITIVE MATERIAL alkermes-defa14a_060823.htm DEFA14A 26504
2 GRAPHIC alks-01.jpg GRAPHIC 8972938
3 GRAPHIC alks-02.jpg GRAPHIC 4493972
4 GRAPHIC alks-03.jpg GRAPHIC 3144689
5 GRAPHIC alks-04.jpg GRAPHIC 1139717
6 GRAPHIC alks-05.jpg GRAPHIC 1402949
7 GRAPHIC alks-06.jpg GRAPHIC 1610988
8 GRAPHIC alks-07.jpg GRAPHIC 1556964
9 GRAPHIC alks-08.jpg GRAPHIC 1610806
10 GRAPHIC alks-09.jpg GRAPHIC 1776275
11 GRAPHIC alks-10.jpg GRAPHIC 1478239
12 GRAPHIC alks-11.jpg GRAPHIC 1533718
13 GRAPHIC alks-12.jpg GRAPHIC 1626204
14 GRAPHIC alks-13.jpg GRAPHIC 1669519
15 GRAPHIC alks-14.jpg GRAPHIC 1545361
16 GRAPHIC alks-15.jpg GRAPHIC 1777298
17 GRAPHIC alks-16.jpg GRAPHIC 337074
18 GRAPHIC alks-17.jpg GRAPHIC 8875420
19 GRAPHIC alks-18.jpg GRAPHIC 10146935
20 GRAPHIC alks-19.jpg GRAPHIC 1050593
  Complete submission text file 0001387131-23-007431.txt   76767345
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

EIN.: 981007018 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35299 | Film No.: 231002921
SIC: 2834 Pharmaceutical Preparations